New IPO: It’s raining IPOs today, Wednesday 4th August. IPOs of four companies are open today. The IPOs of Devyani International, Windlas Biotech, Exxaro Tiles and Krsnaa Diagnostics are open for subscription today. Devyani International’s IPO is worth Rs 1838 crore, while Windlass Biotech will raise Rs 401 crore, KRSNAA Diagnostic Rs 1213 crore and Exjaro Tiles Rs 161 crore through IPO. All these IPOs are a mix of fresh issue and offer for sale and all IPOs will be open for subscription till 6th August this week. If an investor wants to bid for all these issues, then according to the upper price of the price band, he will have to invest at least Rs 57,960.
Devyani International IPO
- The IPO of Devyani International Ltd (DIL), the largest franchise company of KFC, Pizza Hut and Costa coffee in India, is worth Rs 1400 crore.
- Fresh shares worth Rs 400 crore will be issued under the IPO, while existing investors will sell 12.5 crore equity shares under the Offer for Sale (OFS).
- This will be the third IPO of a restaurant chain this year after Burger King India and Barbeque-Nation Hospitality.
The price band for the IPO was fixed at Rs 86-90 per equity share. Investors will be able to bid in lots of 165 shares i.e. according to the upper price of the price band, a minimum investment of Rs 14850 will have to be made. - The face value of the shares is Re 1 per share.
- The allotment of shares is expected on August 11 and listing in the market on August 16.
- The company can use the capital raised through the IPO to pay off its debt of Rs 357.8 crore and meet other business needs.
- Devyani International has 655 stores in 155 cities. It is the largest franchise of Yum Brands. Yum Brands Inc. operates several brands like Pizza Hut, KFC and Teco Bell in India.
- Despite COVID-19, Devyani International has continuously expanded its store network. In the last six months, it has opened 109 stores across the country. The company will further expand itself.
Windlas Biotech Limited IPO
- The special thing about this IPO is that till now no pharma formulation company is listed in the Indian stock market. Windlas will be the first company to be listed in this category.
- The company has fixed a price band of Rs 448-460 for its one share. If these shares are allotted at the maximum price of this price band, then the company can be successful in raising Rs 401.53 crore through this IPO.
- Under the IPO, new shares worth Rs 165 crore will be issued, while 51.42 lakh equity shares will be sold under the offer for sale (OFS).
Windlas Biotech’s IPO opens today, know what is the opinion of experts about investment
- The lot size of 30 shares has been fixed for the IPO. According to the upper price of the price band, investors will have to invest at least Rs 13,800.
- The face value per share is Rs.5.
- The allotment of shares is expected on August 11 and listing in the market on August 17.
- The company is one of the top five companies in the Pharmaceuticals Formulation Contract Development and Manufacturing Organization (CDMO) industry in the country. It has been involved in the development, licensing and development of complex generic products including generic products (drugs and nutracells) from product discovery to its development, licensing and sales.
- The company will use the capital raised from the IPO to purchase equipment needed to increase the production capacity of the Dehradun-based factory.
Exxaro Tiles IPO
- Vitrified tiles leading company Exxaro Tiles plans to raise Rs 161.09 crore through IPO. Under this issue, new shares worth Rs 134.23 crore will be issued and shares worth Rs 26.86 crore will be issued by the existing shareholders under Offer for Sale (OFS).
- The company has fixed a price of Rs 118-120 per share for this IPO. The employees will be issued at a discount of Rs 12 per share.
- For this IPO, investors can bid in lots of 125 shares, that is, according to the upper price of the price band, investors will have to invest at least Rs 15,000.
New IPO: Exxaro Tiles IPO opens today, you can bid in the price band of Rs 118-120
- The face value per share is Rs 10.
- The allotment of shares is expected on August 11 and listing in the market on August 17.
- The money raised through the IPO will be used by the company for debt servicing, working capital and general corporate purposes.
- Exxaro Tiles is involved in manufacturing and marketing activities of vitrified tiles. Vitrified tiles are a mixture of clay and silica which is shiny like glass and absorbs less water. There are more than 1 thousand designs of tiles available in the company’s product portfolio in 6 sizes. Its products are exported not only in the country but also in more than 13 countries including America, Poland and Bosnia. It has more than 2 thousand registered dealers.
- Talking about the financials of the company, its PAT has increased continuously for the last three financial years. Its net profit was Rs 8.92 crore in the financial year 2018-19, which increased to Rs 11.26 crore in the next financial year 2019-20 and increased to Rs 15.22 crore in the financial year 2020-21.
Krsnaa Diagnostics IPO
- Krsnaa Diagnostics has fixed a price band of Rs 933-954 for the IPO of Rs 1213.33 crore.
- The face value of the shares will be Rs 5 per share.
- Under the issue, fresh shares worth Rs 400 crore will be issued while 85.25 lakh equity shares will be issued by the existing shareholders under Offer for Sale (OFS).
- The allotment of shares is expected on August 11 and listing in the market on August 17.
New IPO: Krsnaa Diagnostics IPO opens today, premium reaches 43% in gray market
- With Rs 150.8 crore raised through the issue, diagnostic centers will be set up in Punjab, Karnataka, Himachal Pradesh and Maharashtra and Rs 146.08 crore loan will be fully/partially repaid. Apart from this, the fund will also be used for general corporate purposes.
- Investors can bid for a minimum of 15 equity shares. Thus, according to the upper price of the price band, investors will have to invest at least Rs 14310.
- Due to the outbreak of Corona epidemic, there was a tremendous increase in the PCR testing of the company. As per the data available till 31st December 2020, the company has more than 1800 diagnostic centers operating in 13 states of the country. Apart from this, it also operates a teleradiology reporting hub in Pune.
- Krsnaa Diagnostics has a weighted average return on net worth of 9.54 per cent in the last three financial years.
Get Business News ,, latest India News ,, and other breaking news on share market, investment scheme and much more on Business Khabar. Like us on Facebook, Follow us on Twitter for latest financial news and share market updates.
.